Creative Enzymes, a global enzyme technology service provider, has launched an AI-integrated platform designed to accelerate enzyme catalyst development for biomanufacturing. The platform merges computational enzyme engineering with hands-on process development, delivering solutions that are both predictable in silico and practical at industrial scale. This addresses a critical gap: while biocatalysis is established, the speed of enzyme development often lags behind application opportunities, and traditional methods cannot meet the iterative demands of product development.
The platform leverages AI across three fronts: predicting enzyme candidates for specific reactions, designing enzymes constrained by process parameters rather than biological factors, and using molecular features to anticipate process performance. According to Creative Enzymes, this reduces the need for extensive experimental testing of variants, thereby lowering R&D costs and minimizing the risk of process failure by identifying suitable biocatalysts earlier. It also opens routes to molecules previously inaccessible to enzymatic conversion.
The platform comprises three specialized service modules. The first, AI-Driven Biocatalysis Solutions, offers an end-to-end workflow from target reaction analysis to scale-up characterization. It encompasses computational screening against sequence databases and proprietary libraries, process optimization across parameters such as temperature, pH, solvent, substrate loading, and cofactor availability, and scale-up evaluation covering expression yield and operational half-life. Quantitative data is passed between stages, ensuring decisions are empirically driven. For moderately complex targets, this reduces the design-build-test-learn cycle from 12–24 months to 8–12 months.
The second module, AI-Driven Industrial Biocatalysis, focuses on closing the divide between lab-scale performance and commercial production. It covers substrate concentration optimization, cofactor regeneration, product inhibition management, immobilization and formulation development to extend operational lifespan, integration of process analytical technology for real-time quality assurance, and delivery of complete technology transfer packages including SOPs and regulatory documentation. The goal is a fundamentally improved industrial workflow built around the catalytic process.
The third module, AI-Driven Green Biocatalysis, provides sustainability-focused solutions. Enzymatic reactions typically occur in aqueous media at room temperature, minimizing organic solvent use and emissions, reducing heating and cooling requirements, and simplifying purification by minimizing byproduct formation. AI-guided development amplifies these advantages by identifying more efficient enzymes compatible with the process, reducing the environmental footprint of both development and production.
The platform's capabilities were demonstrated in a recent AI-driven case study in transaminase engineering. Researchers developed a 6D protein engineering framework combining interaction energy, solvent effects, and 1.39 million structural fragments to predict beneficial mutations. Five transaminase variants selected by AI, each with nine mutations, exhibited high solubility and catalytic stability at 7-liter fermentation scale. The engineered enzymes convert prochiral ketones to sitagliptin, delivering enantiomeric purity exceeding 99% and conversion rates up to 89% during scale-up production.
The pharmaceutical industry is currently the primary adopter of AI biocatalysis, particularly for asymmetric synthesis of chiral intermediates and replacing hazardous reagents. Agrochemicals and food sectors are also catching on, with agrochemicals fine-tuning toxicology profiles and food achieving cleaner labels through enzymatic modification. Fine chemicals and personal care are beginning to explore the benefits of high-value conversions and milder, more sustainable processes. This platform positions Creative Enzymes to meet growing industry demands for faster, more efficient, and environmentally friendly enzyme development.
